Company / Interest Expense
FENNEC PHARMACEUTICALS INC. Interest Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.1M
FY2025
5-year range
$195.0K / $4.1M
FY2023-FY2025
Trend
+19.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $195,000 to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025.
Increased from $195,000 to $4M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense increased 19.9% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.1M | +19.9% |
| FY2024 | $3.4M | +1640.5% |
| FY2023 | $195.0K | - |
| FY2021 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026